Plasma Exchange in Stiff‐Man Syndrome
Authors:
- 1 February 2001
- journal article
- case report
- Published by Wiley in Therapeutic Apheresis
- Vol. 5 (1) , 64-67
Abstract
Stiff‐man syndrome (STS) is a rare neurological disorder characterized by involuntary axial and proximal limb rigidity and continuous motor unit activity on electromyography (EMG). Autoantibodies to glutamic acid decarboxylase (GAD) present in 60% of the patients are implicated. We report on the use of plasma exchange (PE) in 2 patients with STS whose serum and cerebrospinal fluid were negative for GAD autoantibodies. One patient showed minimal clinical improvement following PE while the second reported subjective improvement, but not any different from that with medications. Based on the results of PE in our patients, it seems that those who are autoantibody negative are less likely to respond. Whether a more aggressive approach to PE will be beneficial remains speculative.Keywords
This publication has 15 references indexed in Scilit:
- Treatment of stiff‐man syndrome with intravenous immune globulinArthritis & Rheumatism, 1994
- Stiff muscles.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitusTrends in Neurosciences, 1991
- Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff‐man syndromeNeurology, 1991
- Stiff-Man SyndromeMayo Clinic Proceedings, 1991
- Patient perception of tics and other movement disordersNeurology, 1991
- Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man SyndromeNew England Journal of Medicine, 1990
- PLASMA EXCHANGE AND IMMUNOSUPPRESSION IN THE STIFF MAN SYNDROMEThe Lancet, 1989
- Baclofen in Treatment of the 'Stiff-Man' SyndromeArchives of Neurology, 1980
- A critical survey of stiff-man syndromeThe American Journal of Medicine, 1967